A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Carmot Therapeutics, Inc.
- Study ID
- NCT06628362
- Phase
- PHASE2
- Status
- Active Not Recruiting
Conditions
- Overweight or Obese
- Type 2 Diabetes Mellitus (T2DM)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Placebo — DRUGPlacebo will be volume-matched and administered subcutaneously (SC) once weekly.
- Enicepatide — DRUGEnicepatide will be administered subcutaneously (SC) once weekly at the randomized dosing regimen.
Study Details
This is a multi-center, randomized, double-blind, placebo-controlled, parallel group dose-finding study to evaluate the efficacy and safety of enicepatide at low, middle, and high doses in participants who are overweight or obese with Type 2 diabetes mellitus (T2DM).
Key Dates
- Start date
- Nov 21, 2024
- Status verified
- Apr 2026
- Primary completion
- Jun 1, 2026
- Completion
- Sep 24, 2026
Study Design
- Enrollment
- 360 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: Arm 1: Placebo
- Experimental: Arm 2: Enicepatide Dose Level 1 (Low)
- Experimental: Arm 3: Enicepatide Dose Level 2
- Experimental: Arm 4: Enicepatide Dose Level 3
- Experimental: Arm 5: Enicepatide Dose Level 4 (High)
Primary Outcome Measure
Percent Change in Body Weight from Baseline to Week 36 [ Time Frame: Baseline to Week 36 ]
Locations (52)
Find similar trials in Birmingham, AL
Related Studies
- Low-Dose Pioglitazone in Patients With NASH (AIM 2)PHASE2 · Recruiting · University of Florida · Gainesville, Florida
- Human Immunodeficiency Virus (HIV) Food InsecuritiesRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- RCT Glargine vs NPH for Treatment of DM in PregnancyPHASE3 · Recruiting · Loyola University · Maywood, Illinois
- CGM for Management of Type 2 Diabetes in PregnancyRecruiting · University of Alabama at Birmingham · Birmingham, Alabama